These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 16788338

  • 1. Topiramate in treatment of patients with chronic low back pain: a randomized, double-blind, placebo-controlled study.
    Muehlbacher M, Nickel MK, Kettler C, Tritt K, Lahmann C, Leiberich PK, Nickel C, Krawczyk J, Mitterlehner FO, Rother WK, Loew TH, Kaplan P.
    Clin J Pain; 2006; 22(6):526-31. PubMed ID: 16788338
    [Abstract] [Full Text] [Related]

  • 2. The impact of topiramate on health-related quality of life indicators in chronic migraine.
    Dodick DW, Silberstein S, Saper J, Freitag FG, Cady RK, Rapoport AM, Mathew NT, Hulihan J, Crivera C, Rupnow MF, Mao L, Finlayson G, Greenberg SJ.
    Headache; 2007; 47(10):1398-408. PubMed ID: 18052949
    [Abstract] [Full Text] [Related]

  • 3. Topiramate in treatment of depressive and anger symptoms in female depressive patients: a randomized, double-blind, placebo-controlled study.
    Nickel C, Lahmann C, Tritt K, Muehlbacher M, Kaplan P, Kettler C, Krawczyk J, Loew TH, Rother WK, Nickel MK.
    J Affect Disord; 2005 Aug; 87(2-3):243-52. PubMed ID: 15985295
    [Abstract] [Full Text] [Related]

  • 4. Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study.
    Nickel MK, Nickel C, Kaplan P, Lahmann C, Mühlbacher M, Tritt K, Krawczyk J, Leiberich PK, Rother WK, Loew TH.
    Biol Psychiatry; 2005 Mar 01; 57(5):495-9. PubMed ID: 15737664
    [Abstract] [Full Text] [Related]

  • 5. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J, CAPSS-277 Investigator Group.
    Clin Ther; 2009 Mar 01; 31(3):542-59. PubMed ID: 19393844
    [Abstract] [Full Text] [Related]

  • 6. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
    Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, Bigal M, Ascher S, Morein J, Wright P, Greenberg S, Hulihan J.
    Headache; 2009 Sep 01; 49(8):1153-62. PubMed ID: 19719543
    [Abstract] [Full Text] [Related]

  • 7. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, TOPMAT-MIG-201(TOP-CHROME) Study Group.
    Cephalalgia; 2007 Jul 01; 27(7):814-23. PubMed ID: 17441971
    [Abstract] [Full Text] [Related]

  • 8. Topiramate treatment in bulimia nervosa patients: a randomized, double-blind, placebo-controlled trial.
    Nickel C, Tritt K, Muehlbacher M, Pedrosa Gil F, Mitterlehner FO, Kaplan P, Lahmann C, Leiberich PK, Krawczyk J, Kettler C, Rother WK, Loew TH, Nickel MK.
    Int J Eat Disord; 2005 Dec 01; 38(4):295-300. PubMed ID: 16231337
    [Abstract] [Full Text] [Related]

  • 9. Analgesic efficacy and safety of tramadol/ acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial.
    Peloso PM, Fortin L, Beaulieu A, Kamin M, Rosenthal N, Protocol TRP-CAN-1 Study Group.
    J Rheumatol; 2004 Dec 01; 31(12):2454-63. PubMed ID: 15570651
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of rofecoxib in patients with chronic low back pain: results from two 4-week, randomized, placebo-controlled, parallel-group, double-blind trials.
    Katz N, Ju WD, Krupa DA, Sperling RS, Bozalis Rodgers D, Gertz BJ, Gimbel J, Coleman S, Fisher C, Nabizadeh S, Borenstein D, Vioxx Chronic Low Back Pain Study Group.
    Spine (Phila Pa 1976); 2003 May 01; 28(9):851-8; discussion 859. PubMed ID: 12941996
    [Abstract] [Full Text] [Related]

  • 11. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
    Diener HC, Agosti R, Allais G, Bergmans P, Bussone G, Davies B, Ertas M, Lanteri-Minet M, Reuter U, Sánchez Del Río M, Schoenen J, Schwalen S, van Oene J, TOPMAT-MIG-303 Investigators Group.
    Lancet Neurol; 2007 Dec 01; 6(12):1054-62. PubMed ID: 17988947
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of tramadol in treatment of chronic low back pain.
    Schnitzer TJ, Gray WL, Paster RZ, Kamin M.
    J Rheumatol; 2000 Mar 01; 27(3):772-8. PubMed ID: 10743823
    [Abstract] [Full Text] [Related]

  • 13. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
    Seeburger JL, Cady RK, Winner P, MacGregor A, Valade D, Ge Y, Zhang Y, Hustad CM, Strickler N, Schaefer E, Connor KM, Ho TW.
    Headache; 2012 Jan 01; 52(1):57-67. PubMed ID: 22078129
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J, Topiramate Chronic Migraine Study Group.
    Headache; 2007 Feb 01; 47(2):170-80. PubMed ID: 17300356
    [Abstract] [Full Text] [Related]

  • 15. Topiramate in essential tremor: findings from double-blind, placebo-controlled, crossover trials.
    Connor GS, Edwards K, Tarsy D.
    Clin Neuropharmacol; 2008 Feb 01; 31(2):97-103. PubMed ID: 18382182
    [Abstract] [Full Text] [Related]

  • 16. A randomized, placebo-controlled study of the impact of the 7-day buprenorphine transdermal system on health-related quality of life in opioid-naïve patients with moderate-to-severe chronic low back pain.
    Yarlas A, Miller K, Wen W, Dain B, Lynch SY, Pergolizzi JV, Raffa RB, Ripa SR.
    J Pain; 2013 Jan 01; 14(1):14-23. PubMed ID: 23200931
    [Abstract] [Full Text] [Related]

  • 17. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine.
    Mei D, Ferraro D, Zelano G, Capuano A, Vollono C, Gabriele C, Di Trapani G.
    Clin Neuropharmacol; 2006 Jan 01; 29(5):269-75. PubMed ID: 16960472
    [Abstract] [Full Text] [Related]

  • 18. Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials.
    Thienel U, Neto W, Schwabe SK, Vijapurkar U, Topiramate Diabetic Neuropathic Pain Study Group.
    Acta Neurol Scand; 2004 Oct 01; 110(4):221-31. PubMed ID: 15355485
    [Abstract] [Full Text] [Related]

  • 19. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
    Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J, Topiramate Pediatric Migraine Study Investigators.
    Headache; 2005 Oct 01; 45(10):1304-12. PubMed ID: 16324162
    [Abstract] [Full Text] [Related]

  • 20. The impact of migraine on daily activities: effect of topiramate compared with placebo.
    Silberstein SD, Loder E, Forde G, Papadopoulos G, Fairclough D, Greenberg S.
    Curr Med Res Opin; 2006 Jun 01; 22(6):1021-9. PubMed ID: 16846536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.